Kent Lake Capital’s Organogenesis Holdings ORGO Stock Holding History

Kent Lake Capital’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$425K	Buy	+151,905	New	+$408K	0.19%	44

Other funds holding ORGO

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Kent Lake Capital's ORGO Position: Q2 2024 in Review

Kent Lake Capital opened a new position in Organogenesis Holdings (ORGO) in Q2 2024: 151,905 shares worth $425K. The stake represents 0.19% of the portfolio and ranks #44 among its holdings.

116 funds tracked by Wall St. Rank hold ORGO as of Q2 2024.

Kent Lake Capital held 151,905 shares of Organogenesis Holdings worth $425K as of Q2 2024.
Organogenesis Holdings was a new Kent Lake Capital position in Q2 2024.
Organogenesis Holdings made up 0.19% of Kent Lake Capital's portfolio in Q2 2024, its #44 holding.
116 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2024.

Based on Kent Lake Capital's 13F filing for Q2 2024, filed 14 Aug 2024.